Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini S, Campilongo F, Marsico S, Giombini E, Muraro E, Rozera G, De Paoli P, Carbone A, Capobianchi MR, Ippolito G, Fiorentini S, Blattner WA, Lu W, Gallo RC, Caruso A.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14331-6. doi: 10.1073/pnas.1514748112. Epub 2015 Nov 2.

2.

The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma.

Venturelli S, Dalla Pria A, Stegmann K, Smith P, Bower M.

Br J Cancer. 2015 Sep 15;113(6):861-3. doi: 10.1038/bjc.2015.301. Epub 2015 Aug 27.

PMID:
26313666
3.

Investigation of spatio-temporal cancer clusters using residential histories in a case-control study of non-Hodgkin lymphoma in the United States.

Nordsborg RB, Sloan CD, Shahid H, Jacquez GM, De Roos AJ, Cerhan JR, Cozen W, Severson R, Ward MH, Morton L, Raaschou-Nielsen O, Meliker JR.

Environ Health. 2015 Jun 5;14:48. doi: 10.1186/s12940-015-0034-7.

5.

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN.

J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44. doi: 10.1093/jncimonographs/lgu013.

6.

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, de Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BC, Skibola CF, Zhang Y, Mbulaiteye SM, Spriggs M, Robinson D, Norman AD, Kane EV, Spinelli JJ, Kelly JL, La Vecchia C, Dal Maso L, Maynadié M, Kadin ME, Cocco P, Costantini AS, Clarke CA, Roman E, Miligi L, Colt JS, Berndt SI, Mannetje A, de Roos AJ, Kricker A, Nieters A, Franceschi S, Melbye M, Boffetta P, Clavel J, Linet MS, Weisenburger DD, Slager SL.

J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14. doi: 10.1093/jncimonographs/lgu005.

7.

Case 2-2011: a 34 year-old man with Fever and abdominal pain.

Taslimi R, Esfandbod M, Mohraz M, Soutodeh M, Rokni H.

Middle East J Dig Dis. 2012 Jan;4(1):55-9. No abstract available.

8.

Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.

Thapa DR, Hussain SK, Tran WC, Dʼsouza G, Bream JH, Achenback CJ, Ayyavoo V, Detels R, Martínez-Maza O.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):229-37. doi: 10.1097/QAI.0000000000000146.

9.

Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Rubinstein PG, Aboulafia DM, Zloza A.

AIDS. 2014 Feb 20;28(4):453-65. doi: 10.1097/QAD.0000000000000071. Review.

10.

Modelling lymphoma therapy and outcome.

Roesch K, Hasenclever D, Scholz M.

Bull Math Biol. 2014 Feb;76(2):401-30. doi: 10.1007/s11538-013-9925-3. Epub 2013 Dec 14.

11.

Human immunodeficiency virus - associated lymphomas: a neglected domain.

Sirsath NT, Channaviriappa LK, Nagendrappa LK, Dasappa L, Sathyanarayanan V, Setty GB.

N Am J Med Sci. 2013 Jul;5(7):432-7. doi: 10.4103/1947-2714.115772.

12.

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, Kaplan LD, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Oriol A, Navarro JT, Dunleavy K, Little RF, Ratner L, Garcia O, Morgades M, Remick SC, Noy A, Sparano JA.

Blood. 2013 Nov 7;122(19):3251-62. doi: 10.1182/blood-2013-04-498964. Epub 2013 Sep 6. Review.

13.

Virus-associated lymphomagenesis.

Tarantul VZ.

Int J Biomed Sci. 2006 Jun;2(2):101-13.

14.

Increased risk of stomach and esophageal malignancies in people with AIDS.

Persson EC, Shiels MS, Dawsey SM, Bhatia K, Anderson LA, Engels EA.

Gastroenterology. 2012 Oct;143(4):943-950.e2. doi: 10.1053/j.gastro.2012.07.013. Epub 2012 Jul 14.

15.

Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.

Novak I, Jaksić O, Kulis T, Batinjan K, Znaor A.

Croat Med J. 2012 Apr;53(2):115-23.

16.

AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy.

Vishnu P, Aboulafia DM.

Adv Hematol. 2012;2012:485943. doi: 10.1155/2012/485943. Epub 2012 Feb 6.

17.

Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.

Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA.

Cancer. 2012 Aug 15;118(16):3977-83. doi: 10.1002/cncr.26723. Epub 2011 Dec 16.

18.

11. Cancers attributable to infection in the UK in 2010.

Parkin DM.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S49-56. doi: 10.1038/bjc.2011.484. No abstract available.

19.

HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ.

Infect Agent Cancer. 2011 Oct 17;6(1):16. doi: 10.1186/1750-9378-6-16.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk